Miniaturized FRET assays and microfluidics: key components for ultra-high-throughput screening
Related Experiment Video
Updated: Oct 19, 2026

11:28
High-Throughput Screening of L-Lactic Acid-Hyperproducing Bacillus coagulans Mutants Using an Automated Droplet Microfluidic Platform
Published on: July 28, 2026
1Aurora Biosciences Corporation, 11010 Torreyana Road, San Diego, CA 92121, USA.
Drug Discovery Today
|August 4, 1999
Abstract:
Assay miniaturization applicable across a wide range of target classes, along with automation and process integration, are well-recognized goals for ultra-high-throughput screening on an industrial scale. This report summarizes the implementation of fluorescence resonance energy transfer (FRET)-based biochemical and cell-based assays in 3456-well NanoWelltrade mark assay plates using key components of Aurora's ultra-high-throughput screening system.

